excipient

ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient[1].

mRNA-Encapsulating Lipid Excipient 1 (Compound 2), a thiocarbamate-based ionizable lipid, serves as an excipient in the formulation of mRNA-encapsulating lipid nanoparticles [1].

Gelucire 44 14 (Gelucire 14 44) acts as a nonionic surface-active excipient and improves fat absorption in rats with impaired lipolysis.

N,N-Dimethylacetamide (DMAc) is a drug excipient with blood-brain barrier permeability and anti-inflammatory activity, acting through inhibition of the NF-κB signaling pathway. N,N-Dimethylacetamide can reduce endotoxin-induced inflammatory responses in vivo.

Sodium dodecyl sulfate(Sodium lauryl sulfate) is a pharmaceutical excipient that is biologically inactive and improves the stability, solubility and processability of pharmaceutical preparations.

Triton X-100 is a non-denaturing detergent that solubilizes lipid membranes. Triton X-100 is commonly used in laboratories and is applied to vaccines at different stages of the manufacturing process. Triton X-100 is listed as an excipient in certain vaccines including split virus influenza vaccines. Triton X-100 is a nonionic surfactant [1] [2].

Cholesterol-PEG-Folate (MW 2000), an excipient, facilitates the preparation of folate-conjugated PEG-liposomes [1].

Trisodium phosphate dodecahydrate serves as a corrosion inhibitor for iron in 0.1 M NaClO4 solutions, effective under both aerated and deaerated conditions. Additionally, it acts as an excipient in pharmaceutical formulations, functioning primarily as a pH regulator and buffer. These excipients, also known as pharmaceutical auxiliaries, are substances utilized in the pharmaceutical manufacturing process besides the active pharmaceutical ingredients. They are crucial for enhancing the stability, solubility, and processability of pharmaceutical products. Moreover, pharmaceutical excipients play a significant role in influencing the absorption, distribution, metabolism, and elimination (ADME) of co-administered drugs, thereby affecting their efficacy and safety [1] [2].

DMG-PEG 2000 (DMG-PEG2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG 2000 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.

DSPE-Fluorescein is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it an ideal and prominent excipient or formulation agent in pharmaceuticals to achieve enhanced therapeutic outcomes. [DSPE-Fluorescein] is also applicable in research on drug delivery.

DSPE-Fluor 488 is a phospholipid known for its excellent biocompatibility and distinctive amphiphilic properties, making it an ideal form and excipient in pharmaceutical formulations for enhanced therapeutic outcomes. It is utilized in the study of drug delivery.

DOPE-PEG-FITC (MW 2000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a primary and suitable excipient or formulation in drug delivery systems for enhanced therapeutic outcomes. Additionally, DOPE-PEG-FITC (MW 2000) is useful in research focused on drug delivery mechanisms.

DOPE-PEG-Azide (MW 1000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a primary and suitable formulating agent or excipient in drug formulations for enhanced therapeutic outcomes. It is utilized in research focused on drug delivery.

DOPE-PEG-Azide (MW 3400) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it a key and suitable excipient or formulation in drug delivery systems for enhanced therapeutic outcomes. It is utilized in research focused on drug delivery.

DOPE-PEG-Azide (MW 5000) is a phospholipid known for its excellent biocompatibility and notable amphiphilic properties, making it an ideal component as a formulation type or excipient in pharmaceuticals for enhanced therapeutic outcomes. It is utilized in drug delivery research.

DSPE-polysarcosine66 is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal primary form or excipient in drug formulations for enhanced therapeutic outcomes. It is used in research for drug delivery.

DSPE-Amide-PEG-Rhodamine (MW 2000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilicity, making it a key and suitable form or excipient in pharmaceutical formulations to achieve enhanced therapeutic outcomes. DSPE-Amide-PEG-Rhodamine (MW 2000) can be employed in drug delivery research.

DOPE-PEG-FITC (MW 5000) is a phospholipid known for its excellent biocompatibility and distinct amphiphilic properties, making it an ideal and primary excipient or formulation in pharmaceuticals to enhance therapeutic outcomes. Additionally, DOPE-PEG-FITC (MW 5000) is utilized in research focused on drug delivery.

DOPE-PEG-Rhodamine B (MW 5000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it an ideal and primary excipient in pharmaceutical formulations for enhanced therapeutic outcomes. It is applicable in the research of drug delivery systems.

DOPE-PEG-Cy5.5 (MW 2000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it a key and suitable excipient or formulation in pharmaceuticals to enhance therapeutic outcomes. DOPE-PEG-Cy5.5 (MW 2000) is applicable in drug delivery research.

DOPE-PEG-Cy5 (MW 5000) is a phospholipid. With excellent biocompatibility and notable amphiphilic properties, phospholipids serve as a primary and suitable formulation or excipient in drug delivery systems, enhancing therapeutic outcomes. DOPE-PEG-Cy5 (MW 5000) is applicable in studies focused on drug delivery.

DOPE-PEG-Cy5.5 (MW 5000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal and primary formulation or excipient in drug delivery to enhance therapeutic efficacy. This compound is applied in research focused on drug delivery methods.

DOPE-PEG-Cy5 (MW 2000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal and essential excipient or formulation type in pharmaceuticals for enhanced therapeutic outcomes. It is applicable in research focusing on drug delivery.

DMPE-PEG-amine (TFA) (MW 2000) is a phospholipid noted for its excellent biocompatibility and significant amphiphilic properties, making it a suitable and key excipient or formulation in drug delivery systems to achieve enhanced therapeutic outcomes. Additionally, DMPE-PEG-amine (TFA) (MW 2000) is applicable in drug delivery research.